ISOPP Conference
BOPA is please to inform our membership that the ISOPP 2019 conference generated a surplus.
In line with HMRC guidance this surplus will be classed as restricted funds and will used to further support membership in meeting the aims and objectives of the conference.
“ In recent years we have seen an explosion in new technology and novel drug therapies. In our quest to keep up with new developments it can be easy to lose sight of what is most important – providing high quality pharmaceutical care for our patients. Delivering a modern oncology pharmacy service with a human touch”
“The ISOPP 2019 symposium will present participants with a rare opportunity to compare practice with colleagues from around the world, and explore the possibilities of improving practice and patient outcomes through research and collaboration”.
The ISOPP committee will develop initiatives to enable the surplus generated to support members in fulfilling these aims and objectives during the course of 2020 and beyond.
